123 related articles for article (PubMed ID: 4382488)
21. Effects of adrenergic agonists and antagonists on potassium metabolism.
Lockwood RH; Lum BK
J Pharmacol Exp Ther; 1974 Apr; 189(1):119-29. PubMed ID: 4823287
[No Abstract] [Full Text] [Related]
22. Cardiac arrhythmias produced by interaction of ouabain and beta-receptor stimulation.
Raper C; Wale J
Eur J Pharmacol; 1969; 6(3):223-34. PubMed ID: 5805364
[No Abstract] [Full Text] [Related]
23. Adrenergic mechanism participating in induction of atrial fibrillation by ACh.
Hashimoto K; Chiba S; Tanaka S; Hirata M; Suzuki Y
Am J Physiol; 1968 Nov; 215(5):1183-91. PubMed ID: 4386850
[No Abstract] [Full Text] [Related]
24. Comparison of some properties of pronethalol and propranolol.
Black JW; Duncan WA; Shanks RG
Br J Pharmacol Chemother; 1965 Dec; 25(3):577-91. PubMed ID: 4380598
[No Abstract] [Full Text] [Related]
25. Adrenoceptive sites in the veins.
Zsoter T; Tom H
Br J Pharmacol Chemother; 1967 Nov; 31(3):407-19. PubMed ID: 4384258
[No Abstract] [Full Text] [Related]
26. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
Côté P; Polumbo RA; Harrison DC
Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
[No Abstract] [Full Text] [Related]
27. The effect of isopropylamino radical on the cardiovascular system.
Toyama S; Amemiya T; Suzuki K
Jpn Circ J; 1968 Mar; 32(3):341-6. PubMed ID: 4386275
[No Abstract] [Full Text] [Related]
28. Modification of the vascular response to isoprenaline by cholinomimetic drugs.
Hamilton TC
Br J Pharmacol; 1971 Jun; 42(2):254-62. PubMed ID: 4326324
[TBL] [Abstract][Full Text] [Related]
29. Some aspects of the cardiac actions of reserpine and pronethalol.
Roberts J; Ehrreich S; Levitt B
Fed Proc; 1965; 24(6):1421-7. PubMed ID: 4379097
[No Abstract] [Full Text] [Related]
30. Some aspects of the anti-arrhythmic activity of reserpine.
Ciofalo F; Levitt B; Roberts J
Br J Pharmacol Chemother; 1966 Oct; 28(1):44-50. PubMed ID: 5972620
[No Abstract] [Full Text] [Related]
31. Influence of pharmacologic or physiologic pretreatment on acute daunomycin cardiac toxicity in the hamster.
Herman EH; Schein P; Farmar RM
Toxicol Appl Pharmacol; 1970 Mar; 16(2):335-44. PubMed ID: 5265248
[No Abstract] [Full Text] [Related]
32. Some pharmacological properties of a new adrenergic beta-receptor antagonist.
Shanks RG; Wood TM; Dornhorst AC; Clark ML
Nature; 1966 Oct; 212(5057):88-90. PubMed ID: 4381648
[No Abstract] [Full Text] [Related]
33. Pharmacologic effects of tetrodotoxin: cardiovascular and antiarrhythmic activities.
Bernstein ME
Toxicon; 1969 Dec; 7(4):287-302. PubMed ID: 5368467
[No Abstract] [Full Text] [Related]
34. Sympathetic involvement in vagal escape and the effects of beta-receptor blocking drugs.
Raper C; Wale J
Eur J Pharmacol; 1969 Oct; 8(1):47-57. PubMed ID: 4391045
[No Abstract] [Full Text] [Related]
35. Species variation in blood pressure responses to mescaline: evidence of histamine release.
Orzechowski RF; Goldstein FJ
Toxicol Appl Pharmacol; 1973 Aug; 25(4):525-33. PubMed ID: 4126341
[No Abstract] [Full Text] [Related]
36. Pronethalol-induced reversal of adrenergic vasodepression.
Moreira MG; Osswald W
Nature; 1965 Dec; 208(5014):1006-7. PubMed ID: 4380450
[No Abstract] [Full Text] [Related]
37. Reserpine induced supersensitivity to isoprenaline on the blood pressure and heart rate of anaesthetized rabbits.
Khatri CK; Qayum A; Yusuf SM
J Pak Med Assoc; 1976 Jul; 26(7):162-5. PubMed ID: 826663
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.
Saxena PR; Mylecharane EJ; Heiligers J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):121-9. PubMed ID: 2931607
[TBL] [Abstract][Full Text] [Related]
39. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
40. [Involvement of alpha 1-adrenergic receptors of the spinal cord in regulating cardiovascular activity].
Zhu GQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Jun; 10(3):191-5. PubMed ID: 2846192
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
